Inari has been the stronger player in PE, with better than 70% share. Importantly, the VTE market remains significantly underpenetrated, with only about 15% to 20% adoption in the U.S. and lower ...

Inari sells devices that treat venous thromboembolism ... "With Inari as the mechanical thrombectomy leader in pulmonary embolism (PE) and deep vein thrombosis (DVT), Inari's products could ...

NARI, with a market capitalization of $2.99 billion, is a commercial-stage medical device ... to Inari Medical’s estimate, there are 1.9 million people with VTE in the United States each year, with 1 ...

Insights into the digital tools that can help improve patient engagement and advance understanding in deep vein thrombosis ...

Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical (NARI.O), opens new tab, which makes devices that treat patients with ...

New York: Medical-device maker Stryker on Monday agreed to acquire Inari Medical, which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion. The deal for ...